市场调查报告书
商品编码
1422992
2024-2032 年家庭医疗保健市场报告(按产品、服务、适应症和地区)Home Healthcare Market Report by Product, Service, Indication, and Region 2024-2032 |
2023年全球家庭医疗保健市场规模达3,922亿美元。展望未来, IMARC Group预计到2032年市场规模将达到7,917亿美元,2024-2032年复合年增长率(CAGR)为7.87%。慢性病发病率的增加、医疗技术的进步、政府优惠政策的实施以及对个人化和具有成本效益的医疗服务的需求不断增加是推动市场的主要因素。
家庭医疗保健是指在舒适的家中向个人提供的医疗和非医疗服务。它可以帮助那些可能正在从疾病、受伤或手术中恢復、管理慢性病或因年龄相关问题而面临挑战的个人。它通常包括熟练的护理、物理和职业治疗、药物管理、伤口护理以及日常生活活动(如洗澡、穿衣和准备膳食)的协助。它促进患者的独立性并提高患者的生活质量,使他们能够留在熟悉的环境中,同时接受个人化和细心的护理。此外,家庭医疗保健是一种经济高效且方便的选择,可根据个人需求进行客製化,确保最佳支援和更高水准的患者满意度。
该市场主要是由慢性病发病率不断上升所推动的。此外,不断增加的人口和易患多种疾病的老年人口更愿意在舒适的家中接受医疗护理和帮助,从而增加了对个性化和持续的家庭医疗服务的需求。此外,医疗技术和远距医疗解决方案的众多技术进步使医疗保健提供者更容易远端监控和管理家中的患者,这是另一个主要的成长诱导因素。除此之外,家庭医疗保健透过减少再入院率和减轻医疗机构的负担提供了具有成本效益的解决方案,从而加速了市场成长。同时,最近爆发的冠状病毒病(COVID-19)大流行加速了家庭护理的采用,由于社会疏远规范,最大限度地减少了暴露风险并确保了安全,从而推动了市场成长。
慢性疾病的盛行率
糖尿病、心臟病、慢性呼吸系统疾病和神经系统疾病等慢性疾病的盛行率在全球范围内变得越来越普遍。这些情况通常需要长期管理、频繁监测和个人化护理,进而影响市场成长。此外,家庭医疗保健服务非常适合透过在家接受护理来满足慢性病患者的需求,患者可以从持续监测、药物管理和日常生活活动支援中受益,这是另一个主要的成长诱导因素。它还提供个人化治疗计划、復健服务和教育,帮助患者有效管理自己的病情,从而加速市场成长。除此之外,它还可以减轻医院和医疗机构的负担,因为慢性病患者通常需要频繁的追踪和持续的支持,从而促进市场成长。此外,透过提供家庭护理,医疗资源可以更好地分配给患有急性和重症的患者,这推动了市场的成长。此外,向家庭护理的转变可以改善患者的治疗效果和生活质量,有助于控製成本和提高医疗服务的效率,从而创造积极的市场前景。
医疗科技的多项进步
医疗技术的不断进步对家庭医疗保健市场产生了重大影响,改变了向患者在家中提供医疗保健服务的方式。此外,远端监控设备的广泛采用使医疗保健提供者能够远端追踪患者的生命体征,例如血压、心率和血糖水平,从而可以及时干预并更好地管理慢性病,从而影响市场生长。此外,智慧药丸分配器、智慧病床和远端控制医疗设备等物联网(IoT)设备的集成,提高了患者的安全性和便利性,确保遵守治疗计划并降低不良事件的风险,代表着另一个主要的生长诱导因素。除此之外,患者记录的日益数位化允许医疗保健提供者之间无缝共享医疗信息,增强护理协调并全面了解患者的健康史,从而加速市场成长。
落实政府优惠政策
各国政府正在改变家庭照护的潜在好处,并推出支持政策来促进其采用。此外,许多政府正在向提供家庭医疗保健服务的医疗保健提供者和机构提供财政激励和补贴,以鼓励扩大家庭护理并改善患者的就医机会,特别是在服务不足的地区,这正在影响市场的成长。此外,政府正在放宽对家庭医疗保健提供者的监管障碍和许可要求,使他们更容易运作和提供服务,从而促进新参与者进入市场,这是另一个主要的成长诱导因素。除此之外,医疗报销政策进行了修订,纳入了家庭医疗服务的覆盖范围,使患者更能负担得起,这加速了对家庭医疗保健的需求,特别是老年人和慢性病患者的需求,推动了市场的成长。
The global home healthcare market size reached US$ 392.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 791.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.87% during 2024-2032. The increasing incidences of chronic diseases, several advancements in medical technology, the implementation of favorable government policies, and the escalating demand for personalized and cost-effective healthcare services are some of the major factors propelling the market.
Home healthcare refers to medical and non-medical services provided to individuals in the comfort of their own homes. It assists individuals who may be recovering from an illness, injury, or surgery, managing chronic conditions, or facing challenges due to age-related issues. It typically includes skilled nursing care, physical and occupational therapy, medication management, wound care, and assistance with daily living activities such as bathing, dressing, and meal preparation. It promotes independence and improve the quality of life for patients and allows them to remain in familiar surroundings while receiving personalized and attentive care. Additionally, home healthcare is cost-effective and convenient option and are customized to meet individual needs, ensuring optimal support and a higher level of patient satisfaction.
The market is primarily driven by the growing incidences of chronic ailments. Additionally, the increasing population and the growing geriatric populations susceptible to several diseases prefer to receive medical care and assistance in the comfort of their homes, thus escalating the demand for personalized and continuous healthcare services at home. Moreover, numerous technological advancements in medical technology and telehealth solutions made it easier for healthcare providers to remotely monitor and manage patients in their homes represents another major growth-inducing factor. Besides this, home healthcare offers cost-effective solutions by reducing hospital readmissions and easing the burden on healthcare facilities, thus accelerating the market growth. Along with this, the recent onset of the coronavirus disease (COVID-19) pandemic accelerated the adoption of home-based care, due to social distancing norms, minimizes exposure risks, and ensures safety thus propelling the market growth.
The prevalence of chronic ailments
The prevalence of chronic diseases such as diabetes, heart disease, chronic respiratory conditions, and neurological disorders, are becoming increasingly common across the globe. These conditions often require long-term management, frequent monitoring, and personalized care, thus influencing market growth. Moreover, home healthcare services are well-suited to address the needs of patients with chronic diseases by receiving care at home, patients can benefit from continuous monitoring, medication management, and support with activities of daily living which represents another major growth-inducing factor. It also offers personalized treatment plans, rehabilitation services, and education to help patients manage their conditions effectively, thus accelerating market growth. Besides this, it can reduce the burden on hospitals and healthcare facilities, as patients with chronic diseases often require frequent follow-up visits and ongoing support, thus augmenting the market growth. Also, by providing care at home, healthcare resources can be better allocated to patients with acute and critical conditions which is propelling the market growth. Furthermore, the shift toward home-based care improves patient outcomes and quality of life and contributes to cost containment and more efficient healthcare delivery, creating a positive market outlook.
Several advancements in medical technologies
The increasing advancements in medical technology are significantly impacting the home healthcare market, transforming the way healthcare services are delivered to patients at their homes. Additionally, the widespread adoption of remote monitoring devices allow healthcare providers to track patients' vital signs, such as blood pressure, heart rate, and blood glucose levels, from a distance, allows timely interventions and better management of chronic conditions, thus influencing the market growth. Moreover, the integration of the Internet of Things (IoT) devices, such as smart pill dispensers, smart beds, and remote-controlled medical equipment, enhance patient safety and convenience, ensuring adherence to treatment plans and reducing the risk of adverse events, represents another major growth-inducing factor. Besides this, the increasing digitization of patient records allows seamless sharing of medical information between healthcare providers, enhancing care coordination and enabling a holistic view of the patient's health history, thus accelerating market growth.
The implementation of favorable government policies
The governments are transforming the potential benefits of home-based care and introducing supportive policies to promote its adoption. Additionally, numerous governments are providing financial incentives and subsidies to healthcare providers and agencies offering home healthcare services to encourage the expansion of home-based care and to improve access for patients, especially in underserved areas, which are influencing the market growth. Moreover, governments are easing regulatory barriers and licensing requirements for home healthcare providers, making it easier for them to operate and offer their services facilitating the entry of new players into the market, representing another major growth-inducing factor. Besides this, the healthcare reimbursement policies are revised to include coverage for home healthcare services, making it more affordable for patients, which is accelerating the demand for home healthcare, particularly among the geriatric population and those with chronic conditions is propelling the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global home healthcare market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, service and indication.
Therapeutic Products
Testing, Screening, and Monitoring Products
Mobility Care Products
Therapeutic products represent the most popular product
The report has provided a detailed breakup and analysis of the market based on the product. This includes therapeutic products, testing, screening, and monitoring products, and mobility care products. According to the report, therapeutic products accounted for the largest market share.
Therapeutic products encompass several medical devices, equipment, and supplies designed to aid in the treatment and management of various health conditions at home. These products include mobility aids such as wheelchairs and walking aids, respiratory devices such as oxygen concentrators and nebulizers, and wound care products including dressings and wound healing agents, thus influencing the market growth. Additionally, therapeutic monitoring devices, such as blood glucose meters and blood pressure monitors, are essential in managing chronic conditions and promoting proactive health management, thus augmenting the market growth.
Moreover, advancements in therapeutic product technology have led to user-friendly designs, portability, and increased effectiveness, further fueling their popularity among patients and caregivers representing another major growth-inducing factor. Besides this, the growing geriatric population and prevalence of chronic diseases are accelerating the adoption of therapeutic products, ensuring improved patient outcomes and better quality of life. Along with this, the inclination toward therapeutic products due to their ability to empower patients with greater independence and control over their healthcare, and offer patients with essential medical care without the need for frequent visits to healthcare facilities are propelling the market growth.
Skilled Nursing
Rehabilitation Therapy
Hospice & Palliative Care
Unskilled Care
Respiratory Therapy
Infusion Therapy
Pregnancy Care
Skilled nursing holds the largest share of the market
A detailed breakup and analysis of the market based on the service has also been provided in the report. This includes skilled nursing, rehabilitation therapy, hospice & palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care. According to the report, skilled nursing accounted for the largest market share.
Skilled nursing is emerging as the dominant service in the home healthcare market. This specialized form of care is provided by trained and licensed nurses who offer comprehensive medical support to patients in the comfort of their homes. It encompasses several healthcare tasks, including wound care, medication management, intravenous therapy, and post-surgical care, thus influencing the market growth.
Additionally, the growing geriatric population and the rising prevalence of chronic illnesses is escalating the demand for skilled nursing services, as patients with complex medical conditions seek personalized and continuous care, thus accelerating the market growth. Also, skilled nursing at home allows patients to avoid hospital stays and reduce the risk of infections, while also providing convenience and comfort during their recovery process.
Cancer
Respiratory Diseases
Movement Disorders
Cardiovascular Diseases & Hypertension
Pregnancy
Wound Care
Diabetes
Hearing Disorders
Others
Diabetes presently accounts for the largest market share
A detailed breakup and analysis of the market based on the indication has also been provided in the report. These includes cancer, respiratory diseases, movement disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and others. According to the report, diabetes accounted for the largest market share.
Diabetes is emerging as a dominant indication driving the growth of the home healthcare market. Additionally, the increasing incidences of diabetes are escalating the demand for home-based care for diabetic patients, thus influencing market growth. Managing diabetes requires continuous monitoring of blood glucose levels, medication adherence, lifestyle modifications, and regular follow-up with healthcare professionals. Home healthcare offers a convenient and personalized approach to address these needs.
Home-based diabetes care enables patients to receive timely interventions, education, and support in the comfort of their homes, leading to improved disease management and patient outcomes. Additionally, several advancements in medical technology, such as glucose monitoring devices and telehealth solutions, further facilitate remote monitoring and consultation, enhancing the effectiveness of home-based diabetes care. Furthermore, the cost-effectiveness for diabetic patients is particularly appealing, as it reduces the burden on healthcare facilities and minimizes hospital readmissions.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America is currently dominating the home healthcare market, holding the largest share due to the growing geriatric population, rising prevalence of chronic diseases, and advanced healthcare infrastructure driving the demand for home-based healthcare services. Additionally, technological advancements in medical devices and telehealth solutions is further accelerating the adoption of home healthcare in North America.
In Europe, the market is experiencing significant growth due to the growing geriatric population, and the increasing healthcare costs leading to governments and healthcare providers to focus on home-based care as a cost-effective and patient-centric solution. Furthermore, favourable government policies and reimbursement support are encouraging the expansion of home healthcare services across Europe.
The Asia Pacific market is witnessing rapid growth due to its growing population, rising awareness of home-based care options, improving healthcare infrastructure, and an increase in chronic diseases, which are escalating the demand for accessible and personalized healthcare services at home.
Nowadays, key players in the home healthcare market are implementing several strategies to strengthen their position and maintain a competitive edge. They are expanding their range of services to cater to a broader spectrum of patient needs including offering a comprehensive suite of medical, nursing, rehabilitation, and personal care services at home. Moreover, key players are investing in advanced medical technology, remote monitoring devices, telehealth platforms, and mobile health applications to enhance the quality of care, improve patient outcomes, and facilitate remote consultations. Besides this, several companies are prioritizing patient-centric care by customizing services to individual needs, providing personalized treatment plans, and actively involving patients and their families in care decisions. Furthermore, key players are building a robust network of skilled healthcare professionals, including nurses, therapists, and caregivers, to ensure seamless and efficient delivery of services. They are also establishing a strong brand identity and implementing effective marketing strategies to help companies create awareness, build reputation, and attract new patients.
A&D Company Limited
Addus HomeCare Corporation
Amedisys Inc.
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
Fresenius Medical Care AG & Co. KGaA
Invacare Corporation
Koninklijke Philips N.V.
McKesson Corporation
Medline Industries LP
OMRON Healthcare Inc. (Omron Corporation) and ResMed Inc.
Baxter International Inc. made an investment in Medically Home in the home healthcare industry. The company participated in a funding round for Medically Home, which raised $110 million in investment. This investment signifies Baxter's interest and support for at-home acute care services provided by Medically Home.
In May 2020, Fresenius Medical Care AG & Co. KGaA acquired the U.S.-based NxStage that allows company to provide patients with a wide choice of at-home treatment, and improve its offering for home dialysis in Europe, the Middle East, and Africa (EMEA) region.
In January 2022, Omron Healthcare Inc, a prominent key player in remote blood pressure monitoring and personal health technology launched its new remote patient monitoring services with its connected blood pressure monitors and an advanced mobile app designed to support patients and improve home treatment options.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report